Mastektomi Sonrası Anjiosarkomun Sebebi Radyasyon mu? Lenfödem mi? Vaka Sunumu ve Literatür İncelemesi
Öz
Anahtar Kelimeler
Kaynakça
- 1. Fletcher CD. The evolving classification of soft tissue tumours–an update based on the new 2013 WHO classification. Histopathology. 2014;64(1):2-11. 2. Young RJ, Woll P, Staton C, Reed M, Brown N. Vascular-targeted agents for the treatment of angiosarcoma. Cancer chemotherapy and pharmacology. 2014;73(2):259-70. 3. Ravi V, Patel S. Vascular sarcomas. Current oncology reports. 2013;15(4):347-55. 4. Depla A, Scharloo-Karels C, De Jong M, Oldenborg S, Kolff M, Oei S, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. European Journal of Cancer. 2014;50(10):1779-88. 5. Budd GT. Management of angiosarcoma. Current oncology reports. 2002;4(6):515-9. 6. Alhan D, Güzey S, Aykan A, Şahin İ, Işık S, Yıldız R. Meme koruyucu cerrahi sonrası radyoterapi zemininde gelişen anjiosarkom: Olgu sunumu. Gulhane Medical Journal. 2015;57(4). 7. Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001;92(1):172-80. 8. Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, et al. Sarcoma as a second malignancy after treatment for breast cancer. International Journal of Radiation Oncology Biology Physics. 2002;52(5):1231-7. 9. Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. The American journal of surgical pathology. 2004;28(6):781-8. 10. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica. Cancer. 1948;1(1):64-81. 11. Weiss S. Malignant fibrous histicytoma (pleomorphic undifferentiated sarcoma). Enzinger and Weiss's Soft Tissue Tumors. 2008:403-27. 12. WG C. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1(1):3-29. 13. Tomasini C, Grassi M, Pippione M. Cutaneous angiosarcoma arising in an irradiated breast. Dermatology. 2004;209(3):208-14. 14. Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. New England Journal of Medicine. 1995;332(14):907-11. 15. Constantinidou A, Sauve N, Stacchiotti S, Blay J-Y, Vincenzi B, Grignani G, et al. Evaluation of the use and efficacy of (neo) adjuvant chemotherapy in angiosarcoma: a multicentre study. ESMO open. 2020;5(4):e000787. 16. Fayette J, Martin E, Piperno-Neumann S, Le Cesne A, Robert C, Bonvalot S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Annals of Oncology. 2007;18(12):2030-6. 17. Sinnamon AJ, Neuwirth MG, McMillan MT, Ecker BL, Bartlett EK, Zhang PJ, et al. A prognostic model for resectable soft tissue and cutaneous angiosarcoma. Journal of surgical oncology. 2016;114(5):557-63. 18. Buehler D, Rice SR, Moody JS, Rush P, Hafez G-R, Attia S, et al. Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. American journal of clinical oncology. 2014;37(5):473. 19. Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer research. 2000;60(18):5117-24.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Klinik Tıp Bilimleri
Bölüm
Olgu Sunumu
Yazarlar
Sema Rakici
*
Türkiye
Burak Uzunibrahimoğlu
Bu kişi benim
Türkiye
Hatice Küçük
Bu kişi benim
Türkiye
Mürüvvet Akçay
Bu kişi benim
Türkiye
Gonca Hanedan Uslu
Bu kişi benim
Türkiye
Yayımlanma Tarihi
6 Haziran 2022
Gönderilme Tarihi
26 Ağustos 2021
Kabul Tarihi
8 Şubat 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 1 Sayı: 1
